SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007293
Filing Date
2021-05-14
Accepted
2021-05-14 17:16:54
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20210331x10q.htm 10-Q 956109
2 EX-31.1 capr-20210331ex3114c5e7a.htm EX-31.1 9525
3 EX-31.2 capr-20210331ex312d4824e.htm EX-31.2 9387
4 EX-32.1 capr-20210331ex32147dc6c.htm EX-32.1 5746
5 EX-32.2 capr-20210331ex322c63272.htm EX-32.2 5707
  Complete submission text file 0001558370-21-007293.txt   4265273

Data Files

Seq Description Document Type Size
6 EX-101.INS capr-20210331.xml EX-101.INS 719700
7 EX-101.SCH capr-20210331.xsd EX-101.SCH 46585
8 EX-101.CAL capr-20210331_cal.xml EX-101.CAL 27553
9 EX-101.DEF capr-20210331_def.xml EX-101.DEF 162424
10 EX-101.LAB capr-20210331_lab.xml EX-101.LAB 338901
11 EX-101.PRE capr-20210331_pre.xml EX-101.PRE 283578
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 21926011
SIC: 2834 Pharmaceutical Preparations